I remember much of the angst on the board during July, early August over the unveiling of the CD 10 results. As I pointed out at that time that we are invested in a cash poor, still relatively small biotech. When Cydy contracted with Amarex, they could only afford what they foresaw as funds available. Not knowing the contract specifics, I suspect that the type of contract was constrained. If this had been Pfizer, they would have paid for 10 Kush Dowdy and ten assistants to follow up and compile data. We couldn’t Timelines from Nader have varied somewhat due to our small resources but that is why we are invested in this company we so much possible upside!